A whale with a lot of money to spend has taken a noticeably bearish stance on Abbott Laboratories.
Looking at options history for Abbott Laboratories ABT we detected 15 strange trades.
If we consider the specifics of each trade, it is accurate to state that 33% of the investors opened trades with bullish expectations and 66% with bearish.
From the overall spotted trades, 9 are puts, for a total amount of $528,941 and 6, calls, for a total amount of $268,999.
What's The Price Target?
Taking into account the Volume and Open Interest on these contracts, it appears that whales have been targeting a price range from $105.0 to $130.0 for Abbott Laboratories over the last 3 months.
Volume & Open Interest Development
In terms of liquidity and interest, the mean open interest for Abbott Laboratories options trades today is 1444.0 with a total volume of 5,041.00.
In the following chart, we are able to follow the development of volume and open interest of call and put options for Abbott Laboratories's big money trades within a strike price range of $105.0 to $130.0 over the last 30 days.
Abbott Laboratories Option Volume And Open Interest Over Last 30 Days
Biggest Options Spotted:
| Symbol | PUT/CALL | Trade Type | Sentiment | Exp. Date | Strike Price | Total Trade Price | Open Interest | Volume |
|---|---|---|---|---|---|---|---|---|
| ABT | PUT | TRADE | BULLISH | 06/16/23 | $130.00 | $98.7K | 0 | 54 |
| ABT | CALL | SWEEP | BULLISH | 04/21/23 | $105.00 | $72.5K | 3.4K | 217 |
| ABT | PUT | TRADE | NEUTRAL | 01/17/25 | $115.00 | $57.3K | 127 | 389 |
| ABT | PUT | TRADE | BEARISH | 01/17/25 | $115.00 | $56.6K | 127 | 338 |
| ABT | PUT | TRADE | BEARISH | 01/17/25 | $115.00 | $56.6K | 127 | 244 |
Where Is Abbott Laboratories Standing Right Now?
- With a volume of 5,050,200, the price of ABT is up 6.99% at $111.43.
- RSI indicators hint that the underlying stock may be overbought.
- Next earnings are expected to be released in 0 days.
What The Experts Say On Abbott Laboratories:
- UBS downgraded its action to Buy with a price target of $117
- Wells Fargo has decided to maintain their Overweight rating on Abbott Laboratories, which currently sits at a price target of $136.
- Raymond James has decided to maintain their Outperform rating on Abbott Laboratories, which currently sits at a price target of $116.
- BTIG has decided to maintain their Buy rating on Abbott Laboratories, which currently sits at a price target of $130.
- Wells Fargo has decided to maintain their Overweight rating on Abbott Laboratories, which currently sits at a price target of $136.
Options are a riskier asset compared to just trading the stock, but they have higher profit potential. Serious options traders manage this risk by educating themselves daily, scaling in and out of trades, following more than one indicator, and following the markets closely.
If you want to stay updated on the latest options trades for Abbott Laboratories, Benzinga Pro gives you real-time options trades alerts.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Date of Trade | ticker | Put/Call | Strike Price | DTE | Sentiment |
|---|
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
